Skip to main content

Events

There are no upcoming events at this time.

News

  • Fulton Crews quoted on Good Morning America

    Fulton Crews, professor of pharmacology and psychiatry at the UNC School of Medicine, was quoted in an ABC Good Morning America article discussing drinking habits and the benefits of Dry January. The article was originally published in 2018 and was republished this month: Dry January: What is it and how beneficial can giving up alcohol … Read more

  • Lopez discovers new mechanism for allopregnanolone inhibition of inflammatory signaling

    Alejandro Lopez, a graduate research assistant at the Bowles Center for Alcohol Studies, has just discovered a new mechanism for allopregnanolone inhibition of inflammatory signaling. Allopregnanolone inhibits binding of lipopolysaccaride (LPS) to it’s binding site in the binding pocket of the toll-like receptor: Myeloid differentiation factor-2 (TLR4:MD2) protein complex with nanomolar affinity.  Such high affinity … Read more

  • UNC seeks SUD researchers

    Join the #UNCResearch community as part of our first-ever Catalyst Faculty Research Cluster Program. We’re seeking up to four researchers for tenure-track assistant professor positions to build a new cross-disciplinary team that will advance substance use disorder (SUD) treatment from the bench to the bedside. This cluster hiring initiative builds on Carolina’s strengths in public … Read more

  • BCAS Holds Fall Picnic

    The Bowles Center for Alcohol Studies hosted its annual fall picnic on October 26, with members enjoying a warm autumn day filled with pumpkin carving, lawn games, and great company. The sunny weather made it the perfect setting for fun and relaxation. Thank you to everyone who joined us for an fun afternoon!  

  • Clinical Trial on Semaglutide Shows Promise for Treatment of Alcohol Use Disorder, Warrants Further Trials

    Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers. Read more.

 

 

More News…